Information for Patients and Caregivers
ALK+ Lung Cancer
ALK+ lung cancer has unique features that affect who it impacts, how it is treated, and what patients may experience over time. Learn how it relates to other lung cancers, the stages of disease, how it is treated, and the outlook for those who are diagnosed. This information can help patients and caregivers feel more informed, alongside guidance from their healthcare team.
ALK Inhibitor Medication
ALK+ lung cancer is a form of non-small cell lung cancer (NSCLC) caused by a random change in the ALK gene that causes cancer to grow in the lungs. ALK inhibitors are called a targeted therapy because they target the specific cause of ALK cancer. Learn more about how ALK+ lung cancer happens and how ALKi medications work.
ALK Inhibitor Side Effects
All medications can cause side effects, so it is important to know what side effects you might experience from ALKi medications so you can be prepared. When you know what to expect and strategies you can use, side effects become more manageable. Learn what to expect with ALK inhibitor treatment, how to prevent and manage side effects, and when to contact your care team.